--- title: "Soleno Therapeutics (SLNO.US) — 財務報表" type: "Symbol" locale: "zh-HK" url: "https://longbridge.com/zh-HK/quote/SLNO.US/norm.md" symbol: "SLNO.US" name: "Soleno Therapeutics" parent: "https://longbridge.com/zh-HK/quote/SLNO.US.md" datetime: "2026-03-13T19:38:16.468Z" locales: - [en](https://longbridge.com/en/quote/SLNO.US/norm.md) - [zh-CN](https://longbridge.com/zh-CN/quote/SLNO.US/norm.md) - [zh-HK](https://longbridge.com/zh-HK/quote/SLNO.US/norm.md) --- > 支持的語言: [English](https://longbridge.com/en/quote/SLNO.US/norm.md) | [简体中文](https://longbridge.com/zh-CN/quote/SLNO.US/norm.md) # Soleno Therapeutics (SLNO.US) — 財務報表 ## 損益表 (USD) | 指標 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | | --- | --- | --- | --- | --- | --- | | EPS | 0.7903 | 0.4700 | -0.0933 | -0.9479 | -1.28 | | ROE | 36.36% | 28.32% | -7.97% | -73.36% | -87.85% | | Revenue | 91.73M | 66.02M | 32.66M | - | - | | Net income | 42.94M | 26.01M | -4.71M | -43.77M | -55.98M | | Operating income | 40.43M | 22.72M | -5.42M | -42.78M | -58.79M | | Gross margin | 99.06% | 98.27% | 97.87% | - | - | | Net margin | 47.27% | 39.40% | -14.42% | - | - | | Profit quality | 83.01% | 52.28% | - | - | - | ## 資產負債表 (USD) | 指標 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | | --- | --- | --- | --- | --- | --- | | A&L | 563.83M | 599.89M | 332.31M | 318.09M | 330.97M | | Leverage | 1.25 | 1.21 | 1.38 | 1.37 | 1.35 | | BVPS | 8.61 | 9.21 | 4.76 | 4.79 | 5.36 | | Turnover | 0.4256 | 0.2201 | 0.1026 | - | - | | Cash & STI | 305.47M | 498.93M | 286.84M | 289.95M | 291.44M | | Inv & Rec | 15.02M | 6.67M | 2.35M | - | - | | LT assets | 2.38M | 2.46M | 2.60M | 2.78M | 2.98M | | Net debt | -453.54M | -503.42M | -241.07M | -237.16M | -265.82M | ## 現金流量表 (USD) | 指標 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | | --- | --- | --- | --- | --- | --- | | Operating CF | 48.70M | 43.45M | -12.61M | -32.75M | -23.99M | | Investing CF | -125.36M | -91.44M | -7.92M | 22.94M | 6.44M | | Financing CF | -99.90M | 218.15M | 15.69M | 3.22M | 57.06M | | Free CF | 50.85M | 31.02M | 951000.00 | -31.16M | -3.82M | | OCF coverage | 83972.41% | 4345400.00% | -140088.89% | -655040.00% | -299887.50% | | Repaid & issued | - | - | - | - | 49.89M | | CapEx | -58000.00 | -1000.00 | -9000.00 | -5000.00 | -8000.00 |